Skip to Main Content
Center on Emerging Infectious Diseases

  • About
    • Mission
    • Our People
    • Annual Reports
    • Calendar
    • Internships & Jobs
    • Funding Opportunities
  • Research Cores
    • Data Science & Surveillance
    • EIDs, Climate Change, and One Health
    • Public Health, Medical Preparedness, and Response to EIDs
    • Trust and Public Health Communication
  • Projects & Partnerships
    • Biothreats Emergence, Analysis and Communications Network (BEACON)
    • Museum of Science
    • Special Pathogens Unit
    • Boston University and University of Liberia Emerging and Epidemic Virus Research (BULEEVR)
    • NETEC and Special Pathogens Research Network
    • GeoSentinel Surveillance Network
  • Publications
  • Training & Education
    • H5N1 Public Health Resources
    • Trust and Health Communication: An annotated bibliography
    • Long COVID Resources
    • Emerging Infectious Diseases in 5
  • News & Events
    • Blog
    • Center News
    • In the Media
    • Full Calendar
    • Past Events
  • Connect With Us
  • Support our Work
Search

Against Delta, Moderna Edges Pfizer, but Omicron Looms

CEID Founding Director Dr. Nahid Bhadelia shares what is known and what is unknown about the Omicron variant. Read full article here.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to print (Opens in new window)

Against Delta, Moderna Edges Pfizer, but Omicron Looms

Posted 3 years ago

Boston University Center on Emerging Infectious Diseases
111 Cummington Mall, Suite 140, Boston, MA 02215

  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
© 2025 Boston University. All rights reserved. www.bu.edu
  • © 2025 Trustees of Boston University
  • Digital Millennium Copyright Act
  • Privacy Statement
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.